Physician profile
Nancy M Draskovic
NPI 1588696165
$8,398.71
in general payments reported to CMS, 2019-2025
23 companies · $3,277 in 2025
The $3,277 reported for 2025 was more than what 98% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $248 · 2021: $1,239 · 2022: $1,118 · 2023: $871 · 2024: $1,468 · 2025: $3,277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,167 · Consulting Fee: $1,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,166.56 |
| Consulting Fee | $1,450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,102.98 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Bausch & Lomb Americas INC. | $1,183.98 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Allergan, INC. | $1,031.83 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $1,028.84 | 2019-2025 | Cequa |
| Novartis Pharmaceuticals Corporation | $587.68 | 2020-2023 | |
| Harrow Eye, LLC | $381.91 | 2024-2025 | Vevye, Iheezo |
| Alcon Vision LLC | $377.69 | 2019-2025 | Tryptyr, Rocklatan, Eysuvis |
| Kala Pharmaceuticals, INC. | $343.18 | 2021-2022 | |
| Oyster Point Pharma, INC. | $334.06 | 2022-2024 | Tyrvaya, Ryzumvi |
| Tarsus Pharmaceuticals, INC. | $228.47 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $191.78 | 2022-2025 | Oxervate |
| Glaukos Corporation | $166.91 | 2022-2025 | Idosetr |
| Sight Sciences, INC. | $129.05 | 2020-2024 | Omni Surgical System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $59.77 | 2019-2021 | |
| Lkc Technologies, INC. | $45.46 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $44.37 | 2025 | Iyuzeh |
| Rayner Intraocular Lenses Limited | $35.64 | 2022 | |
| Rxsight INC | $31.87 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Eyepoint US, INC. | $22.83 | 2019 | |
| Ocular Therapeutix, INC. | $18.78 | 2019 | |
| New World Medical,INC. | $17.85 | 2023 | |
| Quidel Corporation | $17.28 | 2023 | |
| Johnson & Johnson Surgical Vision, INC. | $16.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Draskovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.